Breaking News
0

Novavax Inc (NVAX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Novavax's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.340 -0.070    -1.59%
22/10 - Closed. Currency in USD ( Disclaimer )
After Hours
4.310
-0.030
-0.691%
17:43:54 - Real-time Data
Type: Equity
Market: United States
ISIN: US6700024010 
CUSIP: 670002401
  • Volume: 396,102
  • Bid/Ask: 4.310 / 4.680
  • Day's Range: 4.260 - 4.520
Invest Now
| AD |
Novavax 4.340 -0.070 -1.59%
Invest Now
| AD |

NVAX Overview

 
This is the main Novavax Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close4.41
Day's Range4.26 - 4.52
Revenue21.21M
Open4.42
52 wk Range0.49 - 11
EPS - 8.71
Volume396,102
Market Cap103.82M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)855,899
P/E RatioN/A
Beta1.91
1-Year Change127.23%
Shares Outstanding23,922,326
Next Earnings DateNov 07, 2019
What is your sentiment on Novavax?
or
Market is currently closed. Voting is open during market hours.

Novavax Inc News


Novavax Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Sell Strong Sell Strong Sell Buy
Technical Indicators BUY Strong Sell Strong Sell Strong Sell Neutral
Summary Buy Strong Sell Strong Sell Strong Sell Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Outside Up 15 Current
Belt Hold Bullish 30 Current
Bullish Engulfing 30 Current
Bullish doji Star 5H Current
Harami Bullish 5H Current
Harami Cross 5H Current
Completed Patterns
Bullish Engulfing 15 1 Oct 22, 2019 03:30PM
Morning Doji Star 15 1 Oct 22, 2019 03:30PM
Morning Star 15 1 Oct 22, 2019 03:30PM

Novavax Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 4.340 4.310 4.680 396,102 -1.59% USD 22/10  
  Berlin 3.880 3.860 3.920 0 -1.52% EUR 02:08:00  
  Munich 3.920 3.860 3.980 0 0.00% EUR 05:23:00  
  Stuttgart 3.960 5.509 5.689 0 0.00% EUR 21/10  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 239.96 242.20 239.62 -0.55 -0.23% 22.68M 22/10  
  Caterpillar 133.69 134.26 130.94 +1.46 +1.10% 4.74M 22/10  
  Facebook 182.34 190.65 181.50 -7.42 -3.91% 19.85M 22/10  
  Alphabet A 1,241.20 1,248.73 1,239.85 -3.08 -0.25% 1.28M 22/10  
  Boeing 337.00 341.48 334.46 +5.94 +1.79% 7.97M 22/10  
  Tesla 255.58 258.33 250.85 +2.08 +0.82% 4.63M 22/10  
  Microsoft 136.37 140.01 136.26 -2.06 -1.49% 27.94M 22/10  
  Amazon.com 1,765.73 1,789.78 1,762.00 -19.93 -1.12% 2.23M 22/10  
  Netflix 266.69 275.41 265.80 -11.36 -4.09% 11.87M 22/10  
  IBM 133.96 134.05 131.61 +1.38 +1.04% 4.20M 22/10  

Novavax Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

379

Equity Type

ORD

Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The Company's lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Securities Investor Protection Corporation (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVAX Comments

Write your thoughts about Novavax Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Geoffrey Lee
Geoffrey Lee Sep 16, 2019 10:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Except for Gold and Silver, it’s gonna be Novavax!
Geoffrey Lee
Geoffrey Lee Sep 04, 2019 9:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What?! All up except you Novavax!
Geoffrey Lee
Geoffrey Lee Aug 14, 2019 12:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why did Novavax bull today? Any good news?
Nabil Din
Nabil Din Aug 14, 2019 12:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ResVax news, they are getting closer
Geoffrey Lee
Geoffrey Lee Jul 19, 2019 9:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Please use your leverage well as you do not have another reverse split. You are going to be delisted very soon if your share keeps dropping like this! Dipstick CEO!
Jeremy Swainston
Jeremy Swainston May 10, 2019 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what a waste
Nate Luchetta
Nate Luchetta May 09, 2019 7:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you see .25 very soon
Rick Lou
Rick Lou Apr 30, 2019 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hope it hits 0.55 or more today
Edgars Luckans
Edgars Luckans Apr 26, 2019 1:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dead
John Doe
John Doe Apr 26, 2019 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
24000 @.4904
Saud Alfahim
Saud Alfahim Apr 17, 2019 2:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to invest
Allan Meyer
RetiredInTexas Apr 16, 2019 5:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gary Mish
Gary Mish Mar 18, 2019 4:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
After the conference call, sounds like a good investment to buy at these prices.
Valery Leshchou
Valery Leshchou Mar 18, 2019 4:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
micro channel.
Valery Leshchou
Valery Leshchou Mar 13, 2019 9:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very interesting
Gary Mish
Gary Mish Mar 11, 2019 5:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is a Beat in Store for Catabasis (CATB) This Earnings Season?.March 07, 2019, 08:51:00 AM EDT By Zacks Equity Research, Zacks.com...Shutterstock photo..We expect Catabasis Pharmaceuticals, Inc. CATB to beat expectations when i t report s fourth-quarter 2018 earnings on Mar 18, before market open...Catabasis beat estimates in three of the past four quarters and missed the same once, delivering average positive surprise of 18.11%. In the last reported quarter, Catabasis delivered a positive earnings
Gary Mish
Gary Mish Mar 11, 2019 5:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shorts better cover tonight before the market opens.
Gary Mish
Gary Mish Mar 11, 2019 5:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Quarter report out On the 18th  one week away , in the pre market, Do the shorts really want to hold when good news comes out, NVAX is going back above $2,00. Only 4 more trading days.
Amer Othman
Amer Othman Mar 11, 2019 7:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I belive we have to see some good signs from the company before buying
Gary Mish
Gary Mish Mar 08, 2019 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to buy, 7 days selling has cleared out all margin calls, forced selling. The news will be good at the quarter report and the stock will jump big. Shorts are to overly invested to the down side..I buy at .531
Rayme Marrero
Rayme Marrero Mar 01, 2019 11:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Look at Tamiflu it's a antiviral but it doesn't get rid of the flu once you get it. it help to prevent the virus from ****you. As a matter fact the side effects of Tamiflu are similar to symptoms of the virus itself. But it got approved. Why?
Rayme Marrero
Rayme Marrero Mar 01, 2019 11:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's far from over. Nothing currently available for rsv.
Aji Jacob
Aji Jacob Feb 28, 2019 12:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I have lost money last time by -80 percent and not sure analysts are hyping this up just before a crash
Aji Jacob
Aji Jacob Feb 28, 2019 12:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I have lost money last time by -80 percent and not sure analysts are hyping this up just before a crash
Rayme Marrero
Rayme Marrero Feb 28, 2019 12:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The purpose of immunization via vaccination is two fold to build some form of immune response from exposure to a attenuate form of a virus to prevent contraction and to prevent death if contracted. It did meet the 1st in a statistical significant manner but it meet the 2nd in a statistical significant manner which is the ultimate goal. To prevent complications and death.
Rayme Marrero
Rayme Marrero Feb 28, 2019 11:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Show me a vaccine with 100% efficacy in prevention. NoneThe results are not great but they are not terrible. It didn't meet the primary end point but it meet secondary end point. It's all relative to what is currently available to prevent RSV and its complications with Pneumonia which there is currently nothing available.
Show more comments
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email